高危前列腺癌根治性前列腺切除术后三级细分系统:对治疗决策的意义
基于美国国家癌症数据库 89,450 例接受根治性前列腺切除术的 cN0M0 患者,按不利中危、有利高危、标准高危和极高危分组,比较不良病理因素和总生存。不利中危与有利高危患者的不良病理因素率(7.6% vs 8.2%)和 5 年 OS(95.7% vs 95.1%)相似,均优于标准高危和极高危患者。三级细分系统可能改善手术患者的治疗选择。
要点
- 不利中危与有利高危前列腺癌患者术后不良病理因素率和 5 年 OS 相似。
- 标准高危和极高危患者不良病理因素率显著更高,OS 更差。
- 高危前列腺癌三级细分可能有助于优化手术患者的治疗决策。
核心结论
- 不利中危或有利高危前列腺癌患者不良病理因素率低且 OS 相似,而标准高危和极高危患者不良病理因素率显著更高且 OS 更差。
- 高危疾病的三级细分可能改善考虑手术患者的治疗选择。
研究设计与样本
- 利用美国国家癌症数据库识别 89,450 例临床 N0M0 的不利中危、有利高危、标准高危或极高危前列腺癌患者,均接受根治性前列腺切除术。
关键数值与推荐
- 有利高危定义:cT1c、Gleason 6、PSA>20 ng/mL 或 cT1c、活检 Gleason 8、PSA<10 ng/mL。
- 标准高危定义:其他 cT3a、活检 Gleason≥8 或 PSA>20 ng/mL。
- 极高危定义:cT3b-T4 或活检主要 Gleason 模式 5。
- 不良病理因素包括阳性手术切缘、T4 疾病或病理淋巴结受累。
临床怎么用
- 对于考虑手术的高危前列腺癌患者,可依据三级细分系统评估不良病理风险和生存,辅助治疗决策。
- 不利中危和有利高危患者术后不良病理因素率低且 OS 相似,可能适合更保守的辅助治疗策略。
- 标准高危和极高危患者不良病理因素率和死亡风险更高,可能需要更积极的围手术期管理或辅助治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To inform treatment decisions for patients with high-risk prostate cancer (PCa), we determined rates of adverse pathologic factors and overall survival (OS) among subgroups of high-risk men. METHODS: Using the National Cancer Database, 89,450 patients with clinical N0M0 unfavorable intermediate-risk, favorable high-risk (cT1c, Gleason 6, prostate-specific antigen [PSA] > 20 ng/mL or cT1c, biopsy Gleason 8, PSA < 10 ng/mL), standard high-risk (all other cT3a, biopsy Gleason ≥ 8, or PSA > 20 ng/mL), or very high-risk (cT3b-T4 or biopsy primary Gleason pattern 5) PCa treated with radical prostatectomy were identified. Rates of adverse pathologic factors (positive surgical margins, T4 disease, or pathologic lymph node involvement) were compared across subgroups. RESULTS: Patients with unfavorable intermediate-risk (n = 31,381) and favorable high-risk (n = 10,296) disease had similar rates of adverse features (7.6% vs 8.2%, adjusted odds ratio 1.00, 95% confidence interval 0.92-1.08, P= .974). Patients with standard high-risk (n = 30,260) or very high-risk (n = 7513) disease were significantly more likely to have adverse pathologic factors (15.9% and 26.5%, P < .001 for both). Patients with unfavorable intermediate-risk and favorable high-risk disease had similar 5-year OS (95.7% vs 95.1%, adjusted hazard ratio 1.06, 95% confidence interval 0.92-1.21, P = .411) but better OS compared to standard and very high-risk patients (93.4% and 88.1%, respectively; P < .001). CONCLUSION: Unfavorable intermediate-risk or favorable high-risk PCa patients had low rates of adverse pathologic factors and similar OS. In contrast, standard and very high-risk PCa patients had significantly higher rates of adverse pathologic factors and worse OS. This 3-tiered subclassification of high-risk disease may allow for improved treatment selection among patients considering surgery.
引用
- Lamba N, Butler S, Mahal BA, et al. Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-making. Urology. 2020. PMID: 32763323. doi:10.1016/j.urology.2020.07.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。